A HindIII polymorphism of fibronectin gene is associated with nephrolithiasis

Metin Onaran1, Akin Yilmaz, Ilker Sen

  • 1Department of Urology, School of Medicine, Gazi University, Ankara, Turkey. monaran@gazi.edu

Urology
|July 21, 2009
PubMed

Insights

The fibronectin gene (FN1) HindIII polymorphism is significantly associated with calcium oxalate nephrolithiasis, suggesting it may serve as a genetic risk marker for kidney stones.

Area of Science:

  • Genetics
  • Nephrology
  • Molecular Biology

Background:

  • Calcium oxalate nephrolithiasis is a common kidney stone disease.
  • Genetic factors play a role in the etiology of nephrolithiasis.
  • Fibronectin (FN1) gene polymorphisms are potential contributors to stone formation.

Purpose of the Study:

  • To investigate the association between fibronectin gene (FN1) polymorphisms and calcium oxalate nephrolithiasis.
  • To identify FN1 gene polymorphisms as potential genetic risk factors for kidney stone disease.

Main Methods:

  • Genomic DNA from 143 nephrolithiasis patients and 154 controls was analyzed.
  • Polymerase chain reaction-restriction fragments length polymorphism was used to screen FN1 gene polymorphisms (HaeIII b, MspI, HindIII).
  • Allele and genotype frequencies were compared between patient and control groups.

Main Results:

  • No significant differences in genotype distributions were observed for HaeIII b and MspI polymorphisms.
  • The FF genotype for the HindIII polymorphism showed a significant association with calcium oxalate nephrolithiasis (P = .00202 and P = .00203).

Conclusions:

  • The HindIII polymorphism of the FN1 gene is strongly associated with calcium oxalate stone disease.
  • FN1 gene variants, particularly the HindIII polymorphism, are potential genetic markers for nephrolithiasis risk.
  • Further research into FN1's role in stone disease etiology is warranted.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...